BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 27001822)

  • 1. Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol.
    Raad I; Chaftari AM; Zakhour R; Jordan M; Al Hamal Z; Jiang Y; Yousif A; Garoge K; Mulanovich V; Viola GM; Kanj S; Pravinkumar E; Rosenblatt J; Hachem R
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3426-32. PubMed ID: 27001822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections.
    Hachem R; Kanj S; Hamerschlak N; Saad H; Assir FF; Mori N; Jiang Y; Ghaly F; Chaftari AM; Raad II
    Expert Rev Med Devices; 2018 Jun; 15(6):461-466. PubMed ID: 29927699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution Is Highly Effective
    Reitzel RA; Rosenblatt J; Gerges BZ; Vargas-Cruz N; Raad II
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932380
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections.
    Chaftari AM; El Zakhem A; Jamal MA; Jiang Y; Hachem R; Raad I
    BMC Infect Dis; 2014 Sep; 14():518. PubMed ID: 25253042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locking Hemodialysis Catheters With Trimethoprim-Ethanol-Ca-EDTA to Prevent Bloodstream Infections: A Randomized, Evaluator-blinded Clinical Trial.
    Rijnders B; DiSciullo GJ; Csiky B; Rutkowski B; Appelt K; Cheronis J; Aitchison R; Gordon G; Jadoul M; Fluck R
    Clin Infect Dis; 2019 Jun; 69(1):130-136. PubMed ID: 30281074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic central line-associated bloodstream infections in children implanted with long term indwelling central venous catheters in a teaching hospital, Sri Lanka.
    Jayaweera JAAS; Sivakumar D
    BMC Infect Dis; 2020 Jun; 20(1):457. PubMed ID: 32600427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol Lock Therapy for the Prevention of Nontunneled Catheter-Related Bloodstream Infection in Pediatric Patients.
    Lopes BC; Borges PSGN; Gallindo RM; Tenório TBS; Machado LB; de Orange FA
    JPEN J Parenter Enteral Nutr; 2019 Nov; 43(8):1044-1052. PubMed ID: 30773689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer.
    Schoot RA; van Dalen EC; van Ommen CH; van de Wetering MD
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008975. PubMed ID: 23799867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
    J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
    Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
    Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central venous catheter salvage in children with Staphylococcus aureus central line-associated bloodstream infection.
    Corkum KS; Jones RE; Reuter CH; Kociolek LK; Morgan E; Lautz TB
    Pediatr Surg Int; 2017 Nov; 33(11):1201-1207. PubMed ID: 28948347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population.
    Weber JM; Sheridan RL; Fagan S; Ryan CM; Pasternack MS; Tompkins RG
    J Burn Care Res; 2012; 33(4):539-43. PubMed ID: 22210071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of alcohol-antibiotic lock therapy for treatment of catheter related bloodstream infections in patients receiving home parenteral nutrition.
    Ławiński M; Majewska K; Fołtyn I; Gradowska A
    Pol Przegl Chir; 2015 Mar; 86(12):563-8. PubMed ID: 25803055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of antimicrobial lock therapy for prevention of central-line-associated bloodstream infections in adult and pediatric cancer patients.
    Norris LB; Kablaoui F; Brilhart MK; Bookstaver PB
    Int J Antimicrob Agents; 2017 Sep; 50(3):308-317. PubMed ID: 28689878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients.
    Chaftari AM; Hachem R; Szvalb A; Taremi M; Granwehr B; Viola GM; Amin S; Assaf A; Numan Y; Shah P; Gasitashvili K; Natividad E; Jiang Y; Slack R; Reitzel R; Rosenblatt J; Mouhayar E; Raad I
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trial.
    Schoot RA; van Ommen CH; Stijnen T; Tissing WJ; Michiels E; Abbink FC; Raphael MF; Heij HA; Lieverst JA; Spanjaard L; Zwaan CM; Caron HN; van de Wetering MD
    Eur J Cancer; 2015 Sep; 51(14):2031-8. PubMed ID: 26188849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer.
    Millar M; Zhou W; Skinner R; Pizer B; Hennessy E; Wilks M; Gilbert RE
    Health Technol Assess; 2011 Feb; 15(7):1-114. PubMed ID: 21294989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central venous catheters and biofilms: where do we stand in 2017?
    Gominet M; Compain F; Beloin C; Lebeaux D
    APMIS; 2017 Apr; 125(4):365-375. PubMed ID: 28407421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of enterococcal central line-associated bloodstream infections in patients with cancer.
    Awadh H; Chaftari AM; Khalil M; Fares J; Jiang Y; Deeba R; Ali S; Hachem R; Raad II
    BMC Infect Dis; 2021 Jul; 21(1):643. PubMed ID: 34225651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.